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snRNPa b s t r a c t
Mutated spliceosome components are recurrently being associated with perturbed tissue develop-
ment and disease pathogenesis. Cephalopho˘nus (cph), is a zebraﬁsh mutant carrying an early prema-
ture STOP codon in the spliceosome component Prpf8 (pre-mRNA processing factor 8). Cph initially
develops normally, but then develops widespread cell death, especially in neurons, and is embryonic
lethal. Cph mutants accumulate aberrantly spliced transcripts retaining both U2- and U12-type
introns. Within early haematopoiesis, myeloid differentiation is impaired, suggesting Prpf8 is
required for haematopoietic development. Cph provides an animal model for zygotic PRPF8 dys-
function diseases and for evaluating therapeutic interventions.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
There is mounting evidence that regulation of pre-mRNA splic-
ing is critical for correct lineage speciﬁcation in haematopoiesis [1–
4]. Spliceosomes are composed of uridine-rich small nuclear ribo-
nucleoprotein particles (U-snRNPs) and multiple associated pro-
teins. The vast majority of introns in pre-mRNA are excised by
U2-dependent major spliceosomes, which contain U1, U2, U4/U6
and U5 snRNPs. PRPF8 (pre-mRNA processing factor 8) is a highly
conserved component of both major and U12-dependent minor
spliceosomes [5,6] with 98% sequence identity between human
and zebraﬁsh proteins. PRPF8 amino acid region 437–770 binds
several U5 snRNP proteins [7,8] and the C-terminal is requiredfor activation of Brr2 helicase unwinding of the U4/U6 duplex
essential for catalytic activation of the spliceosome [9,10]. It has re-
cently been shown that the RNase H region that binds Brr2 also
binds U4/U6 [11,12].
The recent identiﬁcation of recurrent mutations in spliceosome
components in myelodysplastic syndromes (MDS) and MDS-re-
lated secondary leukaemias in multiple genome-wide sequencing
surveys has attracted considerable interest, both for their potential
functional role in MDS pathogenesis, and for their prognostic sig-
niﬁcance [13,14]. An MDS-associated PRPF8 allele has recently
been reported, occurring in a patient with MDS-related secondary
leukaemia [15]. A cluster of varied carboxyl-terminal PRPF8 muta-
tions has previously been implicated in autosomal dominant reti-
nitis pigmentosa [16].
From a forward genetic chemical screen in zebraﬁsh, a mutant
named Cephalopho˘nus (cph) was recovered and shown by posi-
tional cloning to carry a premature stop codon in Prpf8 predicted
to result in a Prpf8-null phenotype. Mutation of this large protein
at the centre of the spliceosome results in pleiotropic phenotypes
that include neural degeneration and defective early haematopoi-
esis, with myelopoiesis more perturbed than erythropoiesis at
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that, at least initially, does not affect all genes uniformly.
2. Materials and methods
2.1. Zebraﬁsh
Strains: St Kilda Wild Type (SKWT; local pet shop, St Kilda, Vic.,
Aust.), WIK, AB, AB (Zebraﬁsh International Research Centre, Eu-
gene, Oregon, USA) and Tübingen (Max-Planck-Institut für Ent-
wicklungsbiologie, Tübingen, Germany). Cephalopho˘nus (cphgl1) is
a novel mutant isolated from an ethylnitrosourea (ENU) mutagen-
esis screen [17]. Fish were housed in the Ludwig Institute for Can-
cer Research Aquarium and ARMI FishCore using standard
husbandry practices. All experiments were approved by the Lud-
wig Institute for Cancer Research or Monash University Animal
Ethics Committees.
2.2. Microinjections
Fertilised 1- to 2-cell embryos were microinjected with prpf8
splice site morpholino oligonucleotide (250 lM in H2O; Gene
Tools, Philomath, OR); or control MO (see Table S2 for sequence),
(250 lM in H2O; Gene Tools) traced where appropriate by mixing
1:1 with 5% rhodamine–dextran.
2.3. Positional cloning
The genomic scan was performed in the laboratory of Dr. L. Zon
(Children’s Hospital, Boston, MA, USA), by Dr. J. Layton, under the
guidance of Helen Foote and Yi Zhou. A 10 cM scan was performed
against a panel of SSLP (simple sequence length polymorphism)
markers, which placed cph on chromosome 15. The region was
subsequently narrowed using RFLP (restriction fragment length
polymorphism) markers and SNP (single nucleotide polymor-
phism) analysis. The Zv7 genome scaffold used as a mapping refer-
ence was incorrectly assembled in this region. Supplementary
Table S2 lists oligonucleotide sequences used.
2.4. Acridine orange staining
Acridine orange (AO) staining was performed as described [18]
and modiﬁed [19]. Embryos were viewed on a Bio-Rad MRC-1024
laser scanning confocal microscope at 2 h intervals between 12 h
post fertilisation (hpf) and 36 hpf. Images were processed using
LaserSharp2000 software.2.5. Gene expression analysis
Whole mount in situ hybridisation (WISH) was performed using
standard techniques [20]. For antibody staining details refer to
Supplementary methods. Whole embryos were visualised using a
Leica MZ6 stereo dissecting light microscope (Leica Microsystems,
Gladesville, N.S.W., Aust.). Anti-active caspase 3 immunoﬂuores-
cence was detected by Alexaﬂuor-conjugated secondary antibody
(Molecular Probes) and confocal microscopy as in Section 2.4.
2.6. Histology
Embryos for sectioning and staining were ﬁxed o/n in 4% para-
formaldehyde, embedded in 1% Bacto-Agar (DIFCO) and stored in
70% ethanol before out-sourcing to the histology unit at the Walter
and Eliza Hall Institute, Parkville, Victoria, Aust. Embryos were sec-
tioned (transverse or sagittal) at 3 lm intervals, stained with hae-
matoxylin and eosin and viewed on a Nikon Microphot FX uprightcompound microscope. Images were captured with a SPOT-1
cooled CCD digital camera (Diagnostic Instruments Inc., Sterling
Heights, MI, USA).
2.7. Genotyping
From 28 hpf, cph embryos were readily recognised in a Mende-
lian proportion by their pleiotropic phenotypes including small
eyes, disrupted neural region, lack of ventricle inﬂation, and thin-
ner yolk extension. Younger cph embryos were genotyped by PCR
using exon 8 primers (oligonucleotides, Table S2; 20 ll reactions;
Phusion polymerase [New England Biolabs, MA] with supplied
GC buffer; 95 C, 2 min followed by 45 cycles at 95, 60 C, and for
30, 30, and 60 s, respectively, and 1 cycle of 10 min at 72 C; PCR
products were gel puriﬁed, then sequenced).
2.8. Preparation of embryo extracts, glycerol gradient centrifugation
and northern blotting
Extracts from 2 dpf larvae were prepared in buffer G (20 mM
HEPES, adjusted to pH 7.9 with KOH, 150 mM KCl, 1.5 mM MgCl2,
1 mM DTT, 0.5 mM PMSF, 0.02% NP40) + 8% glycerol, layered onto
10–30% glycerol gradients in buffer G and centrifuged for 19 h at
39500 rpm in an SW40 rotor at 4 C in an Optima L-90K ultracen-
trifuge (Beckman Coulter). Samples were separated into 20 frac-
tions. RNA was extracted by phenol–chloroform and separated by
electrophoresis on 10% polyacrylamide/8 M urea–TBE gels. After
transfer of nucleic acids to Hybond-N nylon membrane (GE Health-
care), membranes were hybridised with 32P-radiolabelled probes
to zebraﬁsh U2, U4, U5, U6, U11 and U12 snRNAs (Table S2).
2.9. Splicing analysis by RT-PCR
WT and sibling mutant embryos were harvested at 48 hpf in
Trizol. Total RNA was isolated and cDNA synthesised by standard
methods. PCR was performed: 98 C, 30 s; [98 C, 30 s; 65 C
(60 C for exon skipping), 15 s; 72 C, 30 s]  30; 72 C, 7 min,
using splice site primers as described [21,22].3. Results
3.1. Loss of Prpf8 results in neural degeneration due to apoptosis
Cephalopho˘nus (cph) is a recessive zebraﬁsh mutant recovered
from an ENU forward genetics screen for myeloid defects. Under
bright ﬁeld microscopy, gross morphology of homozygous mutants
appears normal until 28 hpf after which time the entire brain and
spinal cord become opaque due to widespread cell death through-
out the central nervous system (Fig. 1A). The embryos develop
kyphosis, and display a twitch in response to touch stimuli
(Fig. 1C). Despite this extensive cell death, development continues,
but over the next 48 hpf, the whole embryo progressively degener-
ates. Circulatory defects are accompanied by increasing pericardial
oedema (Fig. 1D) and mutants die by 96 hpf.
Staining by acridine orange, a marker of cell death, from 12 to
28 hpf (Fig. 1E) showed cells positive for acridine orange uptake
were initially scattered similarly throughout both wild type and
mutant embryos at 12–14 hpf. Their relative abundance progres-
sively diminished in WT embryos but markedly increased in cph
mutants with an anatomically unconstrained distribution, indicat-
ing a general effect on undifferentiated neuroepithelium as well as
multiple other cell types. Immunostaining for active caspase-3
recapitulated the pattern of acridine orange staining (Fig. 1F), sug-




Fig. 1. Neuronal cell death in cph occurs via apoptosis. (A–D) are bright ﬁeld microscopy. (A) Cph 30 hpf embryos display cranial opacity (arrows), indicative of CNS
degeneration, compared to WT siblings (B). (C) At 48 hpf, cph develop severe pericardial oedema and curvature of the spine (kyphosis). (D) At 72 hpf, cph (below) are much
smaller than age-matched WT (above), with weak heart beat and circulation. (E) WT (above) and cphmutant sibling (below) from 12 to 28 hpf. Cph shows a marked excess of
cells with nuclear uptake of acridine orange compared to WT from 14 to 16 hpf, most predominantly in the neuraxis; and (F) Anti-active caspase 3 staining in WT (above) and
cph mutant sibling (below) from 12 to 30 hpf, demonstrating increased number of apoptotic cells in cph.
Fig. 2. Neural patterning and speciﬁcation occurs in cph. Whole mount in situ hybridisation at 30 hpf (A–H) and 28 hpf (I–N) showing similar staining patterns for WT and cph
indicating neural speciﬁcation occurs normally for krox20 (A–D), otx1 (E–H), and foxd3 (I–N) lineages. Alternating lateral and dorsal views, anterior to the left (A–L). (M–N),
dorsal. R3, r5, hindbrain rhombomeres; t, telencephalon; di, diencephalon; n, nose; r, retina; ba, brachial arches; ov, otic vesicles.
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Fig. 3. Positional cloning of cph gene, prpf8. Panel A (i) Genetic map; cM, centimorgans; SSLP, simple sequence length polymorphism; SNP, single-nucleotide polymorphism.
(ii) Physical map containing the critical interval with four candidate genes: nod3 (Nucleotide-binding oligomerisation domain), myo1c (Myosin1c), prpf8, and rilp (Rab
interacting lysosomal protein); (B) schematic of Prpf8 protein with cphmutation shown by red cross. Sequence motifs that are likely to have functional roles are shown: NLS,
nuclear localisation signal; U5, U5 binding site; RRM, RNA recognition motif; 50SS, 50 splice site ﬁdelity; 30SS, 30 splice site ﬁdelity; MPN, Mpr-1, Pad-1, N-terminal domain; site
of retinitis pigmentosa mutations indicated by red bar. (C) Sequence chromatograph, with cph E396X mutation in red; cross marks the G > T transversion.
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speciﬁcation
Despite widespread neural cell death, cph brains showed evi-
dence of normal neural induction, morphogenesis and regionalisa-
tion with formation of speciﬁc structures (Fig. S1A–D). Neuronal
speciﬁcation and differentiation also proceeded in cph with sur-
prising normality at 28–30 hpf (Fig. 2; Table S1). Together, these
data indicate that, neuronal cell death notwithstanding, early neu-
ral patterning and speciﬁcation were able to proceed in cph
embryos.
3.3. A premature stop mutation in prpf8 underpins cephalopho˘nus
A genomic scan positioned the cph mutation on chromosome
15. Intermediate mapping conﬁned the mutation to within a
4.5 cM interval between SSLP markers z22430 and z31583. Recom-
binants identiﬁed using SNP and RFLP markers that were devel-
oped in the interval and a mapping panel totalling 4,700
informative meioses narrowed the genetic interval to 4 genes
(Fig. 3A, i and ii). One of these genes, prpf8, was a likely candidate
on several grounds including its ubiquitous expression pattern
[23,24] and that it is a component of the spliceosome and topo-
some. Defects in genes involved in RNA processing are known to
cause central nervous system (CNS) degeneration in zebraﬁsh mu-
tants [25–27]. Prpf8 cDNAs were cloned and sequenced from cphmutant and wild-type embryos, and a G > T transversion was iden-
tiﬁed in exon 8 (out of 42) which changed E396 into a premature
stop codon (GAG > TAG) (Fig. 3B and C). The G > T mutation was
not present in the somatic DNA of the ENU-treated founder from
which cph was derived, conﬁrming it was ENU-induced.
Given the prpf8 cDNA predicts a full-length protein of 2342
amino acids, truncation of such a large and highly conserved
protein to 395 amino acids is likely a null mutation, and there-
fore a strong candidate for the causative mutation. The causality
of the prpf8 mutation was supported by phenocopy of cph fol-
lowing prpf8 knockdown in WT embryos using a morpholino
antisense oligonucleotide targeted to the ﬁrst exon/intron splice
site in prpf8. Increased acridine orange staining was observed in
94% (67/71) of injected embryos, compared to 0% of control
(non-injected) embryos and 0% of control morpholino injected
embryos.
3.4. Myeloid development requires Prpf8
Recurrent mutations in spliceosome components including
PRPF8 have recently been identiﬁed in myelodysplastic syn-
dromes prompting a survey of the expression of haematopoietic
marker genes in cph at 28 hpf by whole mount in situ hybridisa-
tion (WISH). Myelomonocytic markers were all reduced in cph
compared to WT siblings (Fig. 4A–F). In contrast, expression of
the haemoglobin component gene, hbae3, and o-dianisidine stain-
Fig. 4. Erythrocytes appear normal in cph but myeloid development is affected. A-I are whole mount in situ hybridisation (WISH) gene expression analyses with
myelomonocytic (A–F), erythroid (G), runx1 (H) scl (I) markers. (J) is o-dianisidine staining of haemoglobin. (K) ﬂk1 WISH analysis of developing endothelium; bracket
indicates the distance between the aortic arch and developing eye. WT and cph embryos were collected at: A–H, 28 hpf; I, 72 hpf; J, 3dpf. nMLF, nucleus of the medial
longitudinal fasciculus; isv, intersomitic vesicle; da, dorsal aorta; vv, ventral vein; ICM, intermediate cell mass.
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tween WT and mutant (Fig. 4G and J) suggesting that myeloid cell
development may be initially more dependent on zygotic prpf8
transcription than erythropoiesis. Interestingly, the master hae-
matopoietic regulator scl was ectopically expressed in cph mu-
tants compared to WT siblings (Fig. 4I). By 28 hpf, WT scl
expression is restricted to neural progenitor populations within
the brain (e.g. nMLF). cph mutants, however, retain strong expres-
sion of scl in the hematopoietic regions at 28 hpf, where scl marks
blood and vascular-fated cells in the region of the emergent dor-
sal aorta and intermediate cell mass (ICM). Although this pattern
is reminiscent of that seen in younger 24 hpf WT embryos, in cph
there is striking concurrent normal expression of scl in the nMLF
at 28 hpf which has not yet initiated in 24 hpf WT siblings. Flk1,
marking the endothelium, is also aberrantly strongly expressed
in the developing trunk and intersomitic vessels at 30 hpf in
cph (Fig. 4K).3.5. Splicing defects occur in cph mutants
To determine if the spliceosome was functional in prpf8 mu-
tants, splicing of pre-mRNA molecules was assessed by RT-PCR
across a range of genes previously characterised for splicing aber-
rations in other published studies [1,28–30] including haematopoi-
etic (gata1, hbbe1,mpx,mmp9), signalling (mapk3,mapk8,mapk12),
tumour suppressor (p53), and housekeeping (tubulin) genes. At
48 hpf, cph showed accumulation of transcripts retaining both ma-
jor and/or minor class introns for the erythroid gene gata1, for
mapk12 and p53 but not tubulin (Fig. 5A and B). When cph was as-
sessed for splicing of its prpf8mutant transcript, intron 7–8 was re-
tained (Fig. 5A). Further splicing analysis in haematopoietic genes
revealed an inverse proportion of exon 1/2/3/4 transcripts versus
exon 1/3/4 splice variants for the myeloid gene spi1 indicating
exon 2 is moreoften skipped in cph compared to WT (Fig. 5C). Exon




Fig. 5. Splicing and snRNP assembly is impaired in cph mutants. Semi-quantitative
RT-PCR using template prepared from 48 hpf embryos and primers that span U2-
type (A) U12-type (B) introns 6 300 bp and alternatively spliced exons (C);
numbers in gata1 and spi1 refer to proportion of exon-skipped versus non-skipped
transcripts (ImageJ). NTC, no template control; G, genomic DNA; cph, cph mutant,
WT, wild-type; RT, reverse transcriptase; (+) plus RT; () minus RT. Asterisks (⁄)
mark intron retention. (D) Northern analysis of glycerol gradient fractionation for
U2, U11, U12, U4, U5 and U6 snRNAs in WT and cph extracts. Direction of the
gradient is marked, fractions are numbered, solid triangles mark drop-off in cph
fractions.
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U2, U11 and U12 snRNAs of the major and minor spliceosomes
and U4 snRNA revealed no differences between cph and WT. Anal-
ysis of U5 and U6 proﬁles showed that these snRNAs are present in
both WT and cph, however, cph U5 and U6 are not associated with
the higher molecular weight complexes seen in WT proﬁles sug-
gesting that C-terminal truncation of Prpf8 interferes with tri-
snRNP assembly (Fig. 5D).4. Discussion
It is increasingly evident that regulation of pre-mRNA splicing
events is crucial in correct haematopoietic lineage speciﬁcation
[1–4]. New in vivo models are needed to dissect the mechanisms
and cell biological consequences of splicing dysfunction. Cph repre-
sents such a model. Four lines of evidence are consistent with cph
being a chemically-induced prpf8 loss-of-function mutation: tight
genetic linkage demonstrated by formal positional cloning and
non-segregation through multi-generational pedigree mainte-
nance of >21 generations; phenotype phenocopy by prpf8 knock-
down; the prpf8 mutation was introduced by ENU as it was not
in the somatic tissue of the mutated male; and biochemical conﬁr-
mation of a consequential splicing defect. Although further genetic
evidence could be contributed by non-complementation with an
independent prpf8 allele, this is as yet unavailable.
The cph model of Prpf8 function shows pleiotropic phenotypes
that include neural degeneration accompanied by defects in mye-
lopoiesis and transcript splicing. Caspase-3 activation implicates
apoptosis in the degenerative process in cph. Further studies are re-
quired to understand the precise nature and kinetics of cell death
in cph. Of note, in cph, neural patterning and neuron speciﬁcation
proceed at a normal developmental pace, independently of the
ongoing cell death, which is likely due to interruption of a wide-
spread cell process necessary for neural cell survival. In contrast,
in the haematopoietic compartment, there may be lineage speciﬁc
defects at the time points examined. The aberrantly strong expres-
sion of scl in the hematopoietic regions of cph at 28 hpf suggests a
requirement for a Prpf8-dependent product in coordinating its
tight temporal down-regulation. Scl is essential for the normal
development of primitive and deﬁnitive haematopoietic lineages
in zebraﬁsh [31] and the prolonged scl expression in cph would
be expected to expand all haematopoietic lineages. However, in
cph, decreased expression of myeloid lineage markers compared
to erythroid markers was observed at 32 hpf. Hence, effective spa-
tio-temporal splicing may be more important for a myelopoiesis-
speciﬁc cofactor(s), and/or downstream pre-mRNA regulatory pro-
cesses may preclude an scl-driven myeloid expansion more so than
erythroid cell speciﬁcation and survival.
Prpf8 C-terminal contacts several U5 snRNP proteins and is
indispensible for activation of Brr2-dependent unwinding of the
U4/U6 duplex required for spliceosome catalytic function [7–9].
The aberrant U5 and U6 sedimentation data suggesting the failure
of U4/6U5 tri-snRNP formation in cph in vivo, are consistent with
in vitro studies underscoring the importance of Prpf8 in spliceo-
some assembly. U4 snRNA higher molecular weight complexes
form in cph however the exact snRNP composition of these is not
known.
Aberrant splicing of transcripts is evident in cph but not uniform
for all genes. For a number of haematopoietic and housekeeping
genes, splicing in cph was indistinguishable from WT. Zebraﬁsh
have an advantage over mice in that the maternal to zygotic tran-
sition occurs later in development allowing for analyses of cell-
essential genes [32]. This maternal contribution can initially rescue
a loss-of-function phenotype prior to destabilisation of maternal
transcripts and onset of zygotic genome activation. Strong expres-
sion of zebraﬁsh prpf8 prior to the mid blastula transition indicates
maternal prpf8 mRNA deposition [23,24]. Differential persistence
of enough maternal Prpf8 protein and transcript in some cell types
rather than others together with wide-ranging variation in tran-
script stability between genes/cells could account for the differen-
tial gene splicing observed in cph. In addition, permanently
retained introns are degraded very efﬁciently by the nuclear
exosome either via non-sense mediated decay (NMD) or
independently of it [33], although treatment of embryos with
cycloheximide to block NMD did not result in increased
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12 genes tested (data not shown).
Splicing of Prpf8 itself is defective in cph. The aberrant tran-
script retains intron 7–8 introducing a stop codon 26 amino acids
downstream of exon 7 prior to the mutation-encoded premature
termination codon in exon 8, further compounding the defects in
cph Prpf8. This suggests Prpf8 is involved in splicing of its own
pre-mRNA and may point to an auto-regulatory feedback mecha-
nism. That splicing defects are not seen in all genes in cph suggests
a subset of pre-mRNAs, including prpf8 itself, that rely particularly
on Prpf8 to strengthen U5/exon interactions necessary for splicing
[34]. It is also possible that Prpf8 functions outside of its role in the
spliceosome to generate the cph phenotype. Full transcriptional
proﬁling using RNAseq would more accurately determine the per-
centage of genes carrying unspliced versus spliced or alternatively
spliced transcripts in cph and provide quantitative information on
spliced versus unspliced transcripts for a given gene.
Several elegant precedents illustrate the utility of zebraﬁsh for
studying spliceosomal protein dysfunction biochemically [35–37]
and as it relates to human disease [25,38–40]. Similarly, knock-
down of prpf8 in zebraﬁsh and rescue of cph mutants will provide
new tools with which to study Prpf8 protein function and a plat-
form for understanding pre-mRNA splicing that will contribute to
a better molecular understanding of spliceosome function. Once
the technical challenges are overcome, a genetic complementation
assay for human PRPF8 allele function can be developed as a verte-
brate model for understanding the molecular pathogenesis of
PRPF8-associated diseases, retinitis pigmentosa and myelodysplas-
tic syndromes (MDS). This will present a whole-organism system
for evaluating potential therapeutic interventions.Acknowledgments
We thank: M. Greer, K. Turner and P. Chamberlain for animal
care; S. Jane, D. Curtis and the Royal Melbourne Hospital Bone Mar-
row Research laboratory for support. This work was supported by
Grants to G.J.L. from NIH (RO1 HL079545), the NHMRC (234708,
461208, 516750, 637395) and ARC (DP0346823). MOC was sup-
ported by an Australian Postgraduate Award. The Australian
Regenerative Medicine Institute is supported by grants from the
State Government of Victoria and the Australian Government.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2013.
05.030.References
[1] English, M.A., Lei, L., Blake, T., Wincovitch Sr., S.M., Sood, R., Azuma, M.,
Hickstein, D. and Paul Liu, P. (2012) Incomplete splicing, cell division defects
and hematopoietic blockage in dhx8 mutant zebraﬁsh. Dev. Dyn. 241, 879–
889.
[2] Liu, P., Barb, J., Woodhouse, K., Taylor, J.G.T., Munson, P.J. and Raghavachari, N.
(2011) Transcriptome proﬁling and sequencing of differentiated human
hematopoietic stem cells reveal lineage-speciﬁc expression and alternative
splicing of genes. Physiol. Genom. 43, 1117–1134.
[3] Bedi, R., Du, J., Sharma, A.K., Gomes, I. and Ackerman, S.J. (2009) Human C/EBP-
epsilon activator and repressor isoforms differentially reprogram myeloid
lineage commitment and differentiation. Blood 113, 317–327.
[4] Yamamoto, M.L., Clark, T.A., Gee, S.L., Kang, J.A., Schweitzer, A.C., Wickrema, A.
and Conboy, J.G. (2009) Alternative pre-mRNA splicing switches modulate
gene expression in late erythropoiesis. Blood 113, 3363–3370.
[5] Grainger, R.J. and Beggs, J.D. (2005) Prp8 protein: at the heart of the
spliceosome. RNA 11, 533–557.
[6] Luo, H.R., Moreau, G.A., Levin, N. and Moore, M.J. (1999) The human Prp8
protein is a component of both U2- and U12-dependent spliceosomes. RNA 5,
893–908.[7] Boon, K.L., Grainger, R.J., Ehsani, P., Barrass, J.D., Auchynnikava, T., Inglehearn,
C.F. and Beggs, J.D. (2007) Prp8 mutations that cause human retinitis
pigmentosa lead to a U5 snRNP maturation defect in yeast. Nat. Struct. Mol.
Biol. 14, 1077–1083.
[8] Boon, K.L., Norman, C.M., Grainger, R.J., Newman, A.J. and Beggs, J.D. (2006)
Prp8p dissection reveals domain structure and protein interaction sites. RNA
12, 198–205.
[9] Maeder, C., Kutach, A.K. and Guthrie, C. (2009) ATP-dependent unwinding of
U4/U6 snRNAs by the Brr2 helicase requires the C terminus of Prp8. Nat.
Struct. Mol. Biol. 16, 42–48.
[10] Weber, G. et al. (2013) Structural basis for dual roles of Aar2p in U5 snRNP
assembly. Genes Dev. 27, 525–540.
[11] Mozaffari-Jovin, S., Santos, K.F., Hsiao, H.H., Will, C.L., Urlaub, H., Wahl, M.C.
and Luhrmann, R. (2012) The Prp8 RNase H-like domain inhibits Brr2-
mediated U4/U6 snRNA unwinding by blocking Brr2 loading onto the U4
snRNA. Genes Dev. 26, 2422–2434.
[12] Galej, W.P., Oubridge, C., Newman, A.J. and Nagai, K. (2013) Crystal structure
of Prp8 reveals active site cavity of the spliceosome. Nature 493, 638–643.
[13] Abdel-Wahab, O. and Levine, R. (2011) The spliceosome as an indicted
conspirator in myeloid malignancies. Cancer Cell 20, 420–423.
[14] Hahn, C.N. and Scott, H.S. (2012) Spliceosome mutations in hematopoietic
malignancies. Nat. Genet. 44, 9–10.
[15] Makishima, H. et al. (2012) Mutations in the spliceosome machinery, a novel
and ubiquitous pathway in leukemogenesis. Blood 119, 3203–3210.
[16] Towns, K.V. et al. (2010) Prognosis for splicing factor PRPF8 retinitis
pigmentosa, novel mutations and correlation between human and yeast
phenotypes. Hum. Mutat. 31, E1361–E1376.
[17] Hogan, B.M. et al. (2006) Speciﬁcation of the primitive myeloid precursor pool
requires signaling through Alk8 in zebraﬁsh. Curr. Biol. 16, 506–511.
[18] Furutani-Seiki, M. et al. (1996) Neural degeneration mutants in the zebraﬁsh,
Danio rerio. Development 123, 229–239.
[19] Rodriguez, M. and Driever, W. (1997) Mutations resulting in transient and
localized degeneration in the developing zebraﬁsh brain. Biochem. Cell Biol.
75, 579–600.
[20] Lieschke, G.J. et al. (2002) Zebraﬁsh SPI-1 (PU.1) marks a site of myeloid
development independent of primitive erythropoiesis: implications for axial
patterning. Dev. Biol. 246, 274–295.
[21] Payne, E.M. et al. (2011) Ddx18 is essential for cell cycle progression in
zebraﬁsh hematopoietic cells and is mutated in human acute myeloid
leukemia. Blood 118, 903–915.
[22] Konig, H., Matter, N., Bader, R., Thiele, W. and Muller, F. (2007) Splicing
segregation: the minor spliceosome acts outside the nucleus and controls cell
proliferation. Cell 131, 718–729.
[23] Kudoh, T., Tsang, M., Hukriede, N.A., Chen, X., Dedekian, M., Clarke, C.J., Kiang,
A., Schultz, S., Epstein, J.A., Toyama, R. and Dawid, I.B. (2001) A gene
expression screen in zebraﬁsh embryogenesis. ZFIN Direct Data Submission
<http://zﬁn.org>.
[24] Thisse, B. and Thisse, C. (2004) Fast release clones: a high throughput
expression analysis. ZFIN Direct Data Submission <http://zﬁn.org>.
[25] Linder, B. et al. (2011) Systemic splicing factor deﬁciency causes tissue-
speciﬁc defects: a zebraﬁsh model for retinitis pigmentosa. Hum. Mol. Genet.
20, 368–377.
[26] Winkler, C., Eggert, C., Gradl, D., Meister, G., Giegerich, M., Wedlich, D.,
Laggerbauer, B. and Fischer, U. (2005) Reduced U snRNP assembly causes
motor axon degeneration in an animal model for spinal muscular atrophy.
Genes Dev. 19, 2320–2330.
[27] Yin, J., Brocher, J., Fischer, U. and Winkler, C. (2011) Mutant Prpf31 causes pre-
mRNA splicing defects and rod photoreceptor cell degeneration in a zebraﬁsh
model for Retinitis pigmentosa. Mol. Neurodegener. 6, 56.
[28] Wutz, D., Shayan, P., Schmahl, G.E., Mild, G.C., Feil, B., Roll, S., Kontny, H.U. and
Niemeyer, C.M. (1999) Gene expression of the hematopoietic cell phosphatase
in juvenile myelomonocytic leukemia. Leuk. Lymphoma 35, 491–499.
[29] Rainis, L. et al. (2003) Mutations in exon 2 of GATA1 are early events in
megakaryocytic malignancies associated with trisomy 21. Blood 102, 981–
986.
[30] Ward, A.C. et al. (2003) The zebraﬁsh spi1 promoter drives myeloid-speciﬁc
expression in stable transgenic ﬁsh. Blood 102, 3238–3240.
[31] Dooley, K.A., Davidson, A.J. and Zon, L.I. (2005) Zebraﬁsh scl functions
independently in hematopoietic and endothelial development. Dev. Biol.
277, 522–536.
[32] Tadros, W. and Lipshitz, H.D. (2009) The maternal-to-zygotic transition: a play
in two acts. Development 136, 3033–3042.
[33] Parker, R. (2012) RNA degradation in Saccharomyces cerevisiae. Genetics 191,
671–702.
[34] Aronova, A., Bacikova, D., Crotti, L.B., Horowitz, D.S. and Schwer, B. (2007)
Functional interactions between Prp8, Prp18, Slu7, and U5 snRNA during the
second step of pre-mRNA splicing. RNA 13, 1437–1444.
[35] Trede, N.S. et al. (2007) Network of coregulated spliceosome components
revealed by zebraﬁsh mutant in recycling factor p110. Proc. Natl. Acad. Sci.
USA 104, 6608–6613.
[36] Rosel, T.D., Hung, L.H., Medenbach, J., Donde, K., Starke, S., Benes, V., Ratsch, G.
and Bindereif, A. (2011) RNA-Seq analysis in mutant zebraﬁsh reveals role of
U1C protein in alternative splicing regulation. EMBO J. 30, 1965–1976.
[37] Rios, Y., Melmed, S., Lin, S. and Liu, N.A. (2011) Zebraﬁsh usp39 mutation leads
to rb1 mRNA splicing defect and pituitary lineage expansion. PLoS Genet. 7,
e1001271.
M.-C. Keightley et al. / FEBS Letters 587 (2013) 2150–2157 2157[38] Hao le, T., Burghes, A.H. and Beattie, C.E. (2011) Generation and
characterization of a genetic zebraﬁsh model of SMA carrying the human
SMN2 gene. Mol. Neurodegener. 6, 24.
[39] Kasher, P.R. et al. (2011) Impairment of the tRNA-splicing endonuclease
subunit 54 (tsen54) gene causes neurological abnormalities and larval deathin zebraﬁsh models of pontocerebellar hypoplasia. Hum. Mol. Genet. 20,
1574–1584.
[40] Lotti, F. et al. (2012) An SMN-dependent U12 splicing event essential for motor
circuit function. Cell 151, 440–454.
